CoChat

Ménage à trois of bacterial and viral pulmonary pathogens delivers coup de grace to the lung

Open access
HUSSELL, T, WILLIAMS, A · 2004 · Clinical and Experimental Immunology
Cited by 19

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Respiratory infections account for more than 4 million deaths worldwide and the inclusion of tuberculosis related deaths pushes this figure close to 8 million [1]. Lower respiratory tract infections are the third leading cause of death worldwide [2] and are a WHO priority for vaccine development. Research into respiratory immune responses is therefore central to the campaign to decrease the global burden of disease. Public recognition of the threat of respiratory infection has recently increased due to publicity surrounding the emergence of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV), which causes atypical pneumonia with high mortality [3–6]. Another significant respiratory pathogen that has also captured media interest is the influenza virus, which uses the surface expressed proteins haemagglutinin and neuraminidase to penetrate host cells [7]. Since these proteins are expressed on the surface of the virus they are exposed to the immune system. Mutations introduced into the viral genome during replication by the RNA polymerase results in antigenically distinct influenza strains (termed antigenic drift), thereby avoiding immune recognition. More alarmingly however, is the swapping of whole gene segments between two different influenza strains infecting the same cell (termed antigenic shift) [8]. Antigenic shift is thought to be responsible for influenza pandemics, including the 1918 ‘Spanish flu’ that killed at least 20 million people (more than that of the first world war) and infected approximately half of the world's population. Unusually, this pandemic was particularly fatal in young adults. Although the sequence of the haemagglutinin gene from the virus is known [9], live virus is not available for study, making the basis for its high pathogenicity so far elusive. The source of Spanish flu is thought to be an avian reservoir and a similar clinical outcome was observed during the ‘chicken flu’ outbreak in Hong Kong in 1997, caused by an avian influenza A (H5N1) strain. Six of 18 infected people died and symptoms associated with this infection were febrile influenza-like illness, upper and lower respiratory tract illness and multiorgan failure [10,11]. Unlike most animal models used to examine infectious disease, humans are never free of previous or concurrent infections. Additional complicating cofactors include malignancy (cancer or autoimmune conditions), toxin ingestion or inhalation (smoking, alcohol or drug abuse), trauma (for example surgery), and congenital defects. The precise combination of events required to cause mortality is often overlooked by focusing only on one pathogen. No one beyond infancy is naïve with respect to infection [12]. Indeed the sequence of infection history alters the response to subsequent unrelated organisms [13,14]. Simultaneous infections are the norm rather than the exception. Immune mediated elimination of one pathogen may allow another to escape unchecked leading to localized or systemic disease [15]. Studies performed during influenza pandemics showed that the incidence of associated bacterial pneumonia ranged from 2 to 18% depending on the population studied [16–18]. Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, α-haemoltic streptococci, Escherichia coli, Neisseria meningitidis, Aspergillus fumigatus and Branhamella catarrhalis are the most prominent described to date [19,20]. This raises a ‘chicken and egg’ question. Does the viral infection predispose to bacterial super infection or vice versa? Also, is it the combination of infections that results in death and disease or an altered reaction to one pathogen? Though bacterial proteases may assist influenza infection by cleaving the heamagglutinin precursor into a form that allows viral attachment [21], more evidence suggests that influenza virus inadvertently assists bacterial replication in the respiratory tract. A paper in this issue of Clinical and Experimental Immunology by Seki et al. [22] investigates the interaction between 3 significant respiratory pathogens: S. pneumoniae, P. aeruginosa and influenza virus. Fatality only occurred in mice infected with all three pathogens and not in those with any two in combination. This is unlike the scenario reported previously in mice coinfected with S. pneumoniae and influenza virus [23,24]; a difference likely attributable to the dose of each pathogen used. The mechanisms by which influenza virus increases the occurrence of secondary bacterial infections are numerous (Fig. 1). The epithelial layer covering the mucosa provides an effective first line barrier preventing pathogen (or commensal) entry (Fig. 1a). Respiratory viruses commonly replicate within the epithelium and may cause cell death by exhaustion of host protein synthesis during replication of the viral genome or direct lysis of the infected cell. Adherent staphylococci are visible in lung autopsy specimens from the 1957–58 pandemic in areas where vir

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2249.2004.02526.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 19

Metadata

Authors
HUSSELL, T., & WILLIAMS, A.
Venue
Clinical and Experimental Immunology
Published
2004-06-15
Volume
137
Issue
1
Pages
8-11
ISSN
  • 0009-9104 (ISSN-L)
  • 1365-2249
OpenAlex
W1837937414
Cited by
19
References
9
FWCI
1.35
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.